Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 16, 2022

SELL
$0.48 - $0.74 $20,400 - $31,450
-42,500 Reduced 76.16%
13,300 $8,000
Q4 2021

Feb 14, 2022

BUY
$0.7 - $1.94 $2,310 - $6,402
3,300 Added 6.29%
55,800 $39,000
Q3 2021

Nov 15, 2021

BUY
$1.82 - $5.71 $15,652 - $49,106
8,600 Added 19.59%
52,500 $97,000
Q2 2021

Aug 16, 2021

SELL
$5.22 - $7.33 $1,044 - $1,466
-200 Reduced 0.45%
43,900 $316,000
Q1 2021

May 17, 2021

SELL
$4.0 - $10.28 $50,000 - $128,499
-12,500 Reduced 22.08%
44,100 $286,000
Q4 2020

Feb 16, 2021

BUY
$2.43 - $4.68 $137,538 - $264,888
56,600 New
56,600 $208,000

Others Institutions Holding HEXO

About HEXO Corp.


  • Ticker HEXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 601,395,008
  • Description
  • HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up b...
More about HEXO
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.